chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Admit 7/14. Vaccine 3/7, 3/28. H/O DM Type II, CAD, HTN. Admit for weakness, diarrhea, cough. COVID +, COVID PNA, acute kidney injury reason for admission. Tx w/abx, steroids, fluids. Did not require O2. DC'd home.
Patient presented to the pharmacy after noticing the injection site causing a red bump at the back of the right arm. She does not complain of pain, but does say that it was red and warm to the touch. Did not describe any treatment options tried at this time. She is seeking medical opinion from her doctor for treatment options at this time.
One week after receiving my second Moderna COVID vaccine, I began to have daily moderate-to-severe heart palpitations. In the past, I have had 1-2 episodes of very mild heart palpitations/year. The palpitations post-Moderna vaccine were different in that they have happened every day, they last longer, and they feel more severe in nature. They became severe for several months, in that the force of the palpitation was much stronger and at times, I felt like my heart was stuttering in my chest. I have also experienced episodes of feeling faint, nauseous, sweating, and increased anxiety, and tachycardia. These episodes are unrelated to any particular activity and may last for several minutes. As a doctor, I don't often seek medical attention but it became clear that these new palpitations were worsening over the course of 3 months.
Soreness on both arms simultaneously since ~10 pm- Took 2 Motrin- no effect Soreness and swelling on left arm increased ~12 am- took 2 Motrin- pain and swelling decreased a little but still can't lift arm without surge of pain  Chills and hot flashes since 4 am interchangeably, Headache on and off since ~12:30 pm - took 2 Excedrin- no effect; took 2 more 4 hours later - no effect Nausea with stomach cramps at ~1:30pm- ate toast and drank herbal tea- symptoms decreased by a little Dizziness around the same time as nausea- sat down in a chair and put head down with eye closed Extreme fatigue- all-day- lots of sleep and water
Wrong vaccine selected for age group. Patient was to receive the pediatric pfizer/10mcg per dose as a booster dose or 3rd dose. However was administered 0.2mL of the 12+ pfizer formulation which was 20 mcg total.  Patient and mother were notified and were aware of the mistake. Patient was monitored for 24 hours, no adverse events reported, and has a follow-up with PCP to ensure no further issues or concerns arise.
Headaches; Became lightheaded; This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number Y2D94, expiry date 21st September 2021) for prophylaxis.   On 8th March 2021, the patient received the 2nd dose of Shingrix. In March 2021, less than a week after receiving Shingrix, the patient experienced headache and light headedness. On an unknown date, the outcome of the headache and light headedness were not recovered/not resolved.   It was unknown if the reporter considered the headache and light headedness to be related to Shingrix.  Additional details were reported as follows: The patient received 2nd dose of Shingrix and began to experienced headaches and became lightheaded. Till the time of reporting, the patient was still experiencing the symptoms. The reporter did not consent to follow-up.
Extreame pain all over my body, every cell every bone. It was so extreme, I was screaming and moaning in pain. I did not seek treatment, because I was hoping it would stop, and I was told it was going to be symptoms. Then after a whole day and night, I was going to go to the emergency room, but then abruptly, it stopped. The reaction from the first shot was not bad, just this 2nd one. I did not checked my temperature. I do not know why I reacted to the second shot. After that reaction, I will not try the booster.
Immediately after recieving his shot, my son said he felt nausous and light-headed, and then had a seizure. It lasted several seconds.
This spontaneous report was received from a health professional (nurse) refers to a patient of unknown demographics. Reporting nurse stated that the patient received a dose of VARIVAX (Merck) on 24-MAR-2015 and then received a dose of M-M-R II on 13-APR-2015 which was less than the minimal interval of 1 month between 2 live virus vaccines. No adverse effects were reported. Outcome of the event, inappropriate schedule of drug administration was unknown. Reporting nurse considered the adverse event to be not related to VARIVAX (Merck) and M-M-R II. Additional information has been requested.
4MAY approx 2 mins of vax pt stated think going to pass out; helped to floor jerking of body approx 90 sec; EMT exam dx acute vaso syncope;
Dizzy; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 20Mar2021, outcome "unknown", described as "Dizzy". Therapeutic measures were not taken as a result of dizziness.  Additional information: Reason for no lot number: of COVID Vaccine: Other: patient stated, "No, patient do not have. Additional Context: patient stated, he took the shot on Thursday and yesterday and today, he had been feeling very dizzy. Start date: patient stated, "Wednesday." (not clarified further) patient further stated, he need some advice, do he need to go to the doctor or hospital as he was feeling dizzy or not. Patient was informed about Pfizer Medical Information department and provided with the number.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swollen armpit node in the same arm that was vaccinated; This is a spontaneous report received from a contactable reporter(s) (Other HCP) via a sponsored program. The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 10:00 (Lot number: FA 7485) at the age of 42 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 06Aug2021 21:00, outcome "not recovered", described as "Swollen armpit node in the same arm that was vaccinated". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications were received within 2 weeks of vaccination. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. No known allergies.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a 6 year old male patient. On 16-AUG-2017 the patient was inadvertently vaccinated with an expired dose of VARIVAX lot # L020000, expiry date on 02-JUN-2017, which was reconstituted with an expired sterile diluent with lot # reported as K016130, expiry date on 21-JUL-2017, for prophylaxis. No adverse effects. Lot number K016130 is an invalid lot number for sterile diluent.
Injection site reaction red, slightly swollen, raised rash at injection site about the size of a tennis ball.
developed shingles in month four; This case was reported by a consumer via call center representative and described the occurrence of shingles in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 4 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced shingles 4 months after receiving Shingrix vaccine.
SEVERE REACTION OF MUCUS BUILD ON BRAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced severe reaction of mucus build on brain. Laboratory data (dates unspecified) included: MRI (NR: not provided) Unknown. The action taken with covid-19 vaccine  was not applicable. The outcome of severe reaction of mucus build on brain was not reported. This report was non-serious.
Headache; muscle and joint aches; muscle and joint aches; This is a spontaneous report from a contactable physician reporting for herself.   A 44-years-old female patient received the first dose of bnt162b2 (BNT162B2, Pfizer product), intramuscular in the right arm on 15Dec2020 12:45 at hospital at single dose for immunisation. Medical history included was none. Concomitant medication included bupropion (unknown manufacturer). The patient experienced headache, muscle and joint aches on 15Dec2020 with outcome of not recovered. No treatment was performed. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  Information on the lot/batch number has been requested.
Fever, day 8 after vaccines. Rash, day 9 after vaccines 2 hours to MMR.  Erythema, pap, blanching rash.
Adverse reactions i endured after getting the vaccine were vomiting, fever, pain in the injection site, headache, diarrhea, fainting, heart palpitations, sharp pains in my abdomen,  very high pulse rate, and brain fog.  I immediately went to the emergency room.  I was admitted at the hospital for Treatment.  Medical care and medication was given  to slow down heart rate, pain,  and reduce vomiting.  Antibiotic was given for  infection .
NO ADVERSE EVENT REPORTED BY PATIENT - PATIENT RECEIVED A  HIGH DOSE FLU SHOT AND 1/2 DOSE MODERNA BOOSTER ON 12/09/2021 AND ANOTHER 1/2 DOSE MODERNA 12/28/2021-  WHEN KEYING HER INFOMATION INTO THE COMPUTER IT WAS DISCOVERED THAT  ACCORDING OUR SYSTEM, THE PATIENT HAD ALREADY RECEIVED HER BOOSTER WHEN SHE CAME IN FOR HER FLU SHOT EARLIER THAT MONTH BUT BY THE TIME OF THE DISCOVERY, THE PATIENT ALREADY RECEIVED THE 2ND BOOSTER VACCINE.
No additional AEs reported; had a previous temperature excursion; expired vaccine was administered; This spontaneous report was received from a registered nurse and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies were not reported.  On 14-APR-2023, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (strength: 50 dosage form, 1 mL, lot #U036184, expiration date: 02-MAR-2023, administered intramuscularly through deltoid (unspecified) for prophylaxis (expired product administered). The suspect vaccine had had a previous temperature excursion (product storage error). The detail of temperature excursion was not reported. No additional adverse event reported (no adverse event).
This spontaneous report was received from a medical assistant refers to a patients of unknown age. On an unknown date, the patients were exposed to temperatures outside of the recommended range, have been vaccinated with MMRII since 01-OCT-2015. No adverse experience has been reported. No additional information was provided. Additional information has been requested.
Fever, muscle aches, weakness, dizzy spells, lack of sleep, back pain, pain at injection site.  Headaches, whole body pain.
I had my vaccination on 11/16/2022. I started to experience malaise and didn't feel well with slight headache and sore throat 01/01/2023. I tested COVID-19 Positive on 01/02/2023. I was prescribed Paxlovid. I feel fine on 04/06/2023.
The patient does not report any issues when the vaccine was actually given (no pain at time of vaccination). Patient went on a 2.5 hour hike after the vaccination and afterwards had a nodule at the injection site. two days later (11/4) he reported warmness, redness, and swelling of his left arm. He went to the MD and they suspect cellulitus and prescribed doxycycline
Been hit by the flu; This case was reported by a consumer via interactive digital media and described the occurrence of influenza in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th October 2020, the patient received the 2nd dose of Shingrix. On 26th October 2020, less than a day after receiving Shingrix, the patient experienced influenza. On an unknown date, the outcome of the influenza was unknown.   It was unknown if the reporter considered the influenza to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient had received the 2nd part of Shingrix vaccine day before reporting date, and on the night of vaccination date, felt like had been hit by the flu. The reporter has questioned whether this was a common reaction.
Round, red, raised area warm to touch (3 to 4 inches). Two rings at site of injection pink/red outer area and closer to the area was a darker pink/red area.
LIGHT-HEADEDNESS; VACCINE IN THE SYRINGE WAS PINK IN COLOR WHEN ADMINISTERED; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180531, and batch number: 180531 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced vaccine in the syringe was pink in color when administered. On 13-MAR-2021, the subject experienced light-headedness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light-headedness on 14-MAR-2021, and the outcome of vaccine in the syringe was pink in color when administered was not reported. This report was non-serious.
Information has been received from a certified medical assistant concerning a 24 year old female with no pertinent medical history and no drug reactions or allergies who on 09-MAR-2011 was vaccinated IM with the first 0.5 ml dose of GARDASIL (Lot Number: 667866/1437Z; Expiration date: 25-FEB-2013). There was no concomitant medication. Recently, on an unspecified date, the patient was diagnosed with infectious mononucleosis. The patient was seen by family physician and sought medical attention. Upon the time of the report, the patient was not recovered. Follow up information has been received from the medical assistant reported that the 24 year old female student with no illness at time of vaccination was diagnosed of infectious mononucleosis which was active when due for the second dose. The second dose was held until the patient recovered. At the time of the report, the patient's present status was unknown. Additional information has been requested.
Patient disclosed that he has passed out before from vaccination. He sat on the floor after vaccinated and even told me just before he fainted that he was going to pass out. He was out for maybe 15 seconds. No injuries. Monitored his blood pressure for approximately 15 minutes. Patient reported he was fine but had him wait another 15 minutes before leaving.
Swelling to both feet with pain (10/10) and erythema.  Increasing symptoms through 7/29 when he was seen in ED with initial dx cellulitis.  Dx changed to lymphedema commonly seen with trainees and unrelated to timing of immunizations which were rescheduled and edema occurred on the same day following arrival at the base.  He likely recovered, but was seen on 8/1 when he was better, but still in pain and difficulty walking.
left eyelid severely swollen; eye lid or perhaps eyeball under lid sore to touch; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot #: unknown), via an unspecified route of administration on 29Dec2020 13:00 in left arm at single dose for COVID-19 immunization. Medical history included seasonal allergy and asthma from an unknown date and unknown if ongoing. Concomitant medication included zinc, vitamin C [ascorbic acid], vitamin B3 and Elipta for asthma. The patient had historical vaccine Tetanus and experienced allergies. On 30Dec2020, the patient woke up the next morning with left eyelid severely swollen then took anithistamine Allegra, it got better as the eye lid or perhaps eyeball under lid sore to touch for next 24 hours but getting progressively better. The facility where the most recent COVID-19 vaccine was administered in a nursing home or senior living facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on unspecified date. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  Information on the lot/batch number has been requested.
I HAD SEVERE BODY ACHES, EXTREME FATIGUE, HEADACHES, CHILLS AND FEVER OVER 100F FOR 48 HOURS. IT WAS UNBEARABLE. I TOOK ADVIL FOR RELIEF.
Cried himself to sleep after shot, slept for 2 hour and woke very cranky and fussy, alternated with Tylenol and Motrin for 5 days, cranky until 6/25. Had temp 2-3 days (over 100). Would grab at right leg often until 6/25 - still occasionally hold right thigh especially when he is in his jumper.
Pt presented with syncope d/t coughing; CXR: clear; dx: Covid infection Tx: solumedrol, Vit C, Vit D3, Zinc, Singulair, lovenox; no criteria met for remdesivir or tocilizumab; minimal O2 support with 1 LPM NC; back to room air baseline by d/c; elequis continued at dc due to elevated d-dimer
I had intense muscle weakness, soreness, and cramping all over my body starting the following day. It lasted 2 days total, so i took Aleve for the pain. I wasn't able to go about my usual activities. Also, the injection site was sore and felt warm from the beginning and lasted several more days.
Flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu). At the time of the report, INFLUENZA (Flu) had resolved.            No Concomitant medication was provided.  No treatment medication was provided.
The patient stated that he received his second dose of GARDASIL 9 "about 6 weeks after the first dose, not 8 weeks like it is recommended.; No adverse symptoms reported.; This spontaneous report was received from a patient of unknown age and gender reporting on herself. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, route, dose, frequency, anatomical location,lot # and expiration date were unknown) for prophylaxis. Additionally, the patient stated that he received his second dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) about 6 weeks after the first dose, not 8 weeks like it is recommended. No adverse symptoms were reported.
Can hardly walk when the leg cramps are going on after booster; Leg cramps from knees to toes after booster; Mild Fever after booster; Mild Chills after booster; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can hardly walk when the leg cramps are going on after booster), MUSCLE SPASMS (Leg cramps from knees to toes after booster), PYREXIA (Mild Fever after booster) and CHILLS (Mild Chills after booster) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A and 044A21A) for COVID-19 vaccination.     The patient's past medical history included Leg cramps (mild leg cramps that flared up every once in a blue moon).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, the patient experienced PYREXIA (Mild Fever after booster) and CHILLS (Mild Chills after booster). On 11-Dec-2021, the patient experienced GAIT DISTURBANCE (Can hardly walk when the leg cramps are going on after booster) and MUSCLE SPASMS (Leg cramps from knees to toes after booster). On 09-Dec-2021, PYREXIA (Mild Fever after booster) and CHILLS (Mild Chills after booster) had resolved. At the time of the report, GAIT DISTURBANCE (Can hardly walk when the leg cramps are going on after booster) and MUSCLE SPASMS (Leg cramps from knees to toes after booster) had not resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-410071 (Patient Link).
STOMACHE ACHE; FEELS LIKE STOMACH IS IN A KNOT; FEELING EXTREMELY TIRED; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180531, and batch number: 180531 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced stomache ache. On 12-APR-2021, the subject experienced feels like stomach is in a knot. On 12-APR-2021, the subject experienced feeling extremely tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from stomache ache, and feels like stomach is in a knot, and the outcome of feeling extremely tired was not reported. This report was non-serious.
Immunization record showed child due for 2nd HPV 9, 1st MCV4, and 1st Tdap. Father agreed to these vaccines at appointment, unaware that child had received all 3 in another state already roughly 2 months prior. Mother of child called us after appointment to notify us child had already received these vaccines.
Narrative: Pt is a 72y.o. male who died on 05/13/2021 w/ h/o malignant neoplasm, overlapping lesion and solitary nodule of lung, HLD, GERD, and anxiety disorder. Pt. received J&J Covid-19 Vaccine 1/1 on 03/25/2021. Pt. died at Hospital on May 13,2021@16:42. Unlikely J&J Covid-19 vaccine contributed to pt death.
Pt recvd 2 doses of Engerix-B & following both doses could not turn neck to side of inject; resolved in 24 hrs;